Fight Against Coronavirus: Nexcelom China Team Provides Assay Development Support to Scientists

Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).

Improving the viral plaque assay speed, sensitivity and robustness using imaging cytometry

Improved fluorescent plaque assay method using fluorescently-labeled antibodies and the use of the Celigo image cytometer.

22nd Annual Merck Technology Symposium

Come visit us at booth #413 Merck Technology Symposium 2018 September 5-6, 2018 Ocean Place Resort Long Branch, NJ Posters being presented: High-throughput foci counting of viral titer and antibody neutralization assays using the Celigo Image Cytometer for developing a novel cross-reactive influenza vaccine Long-term time-course monitoring of NK cell-mediated ADCC using the Celigo Image Cytometer A high-throughput 3D tumor spheroid screening method for drug discovery using imaging cytometry

Go to Top